Showing results (281-290 of 722) with videos related to

Sort By:
Pageof 73
The Lancet. Haematology|January 3, 2017
Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA groupFrédéric Peyrade, Serge Bologna, Vincent Delwail, et al.
The Lancet. Haematology|March 15, 2017
Pegylated interferon alfa-2a in patients with essential thrombocythaemia or polycythaemia vera: a post-hoc, median 83 month follow-up of an open-label, phase 2 trialLucia Masarova, Keyur P Patel, Kate J Newberry, et al.
The Lancet. Haematology|March 16, 2019
High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trialColin A Hutchison, Paul Cockwell, Veronica Moroz, et al.
The Lancet. Haematology|November 4, 2018
Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trialTakashi Watanabe, Kensei Tobinai, Masashi Wakabayashi, et al.
The Lancet. Haematology|November 4, 2018
Fludarabine with a higher versus lower dose of myeloablative timed-sequential busulfan in older patients and patients with comorbidities: an open-label, non-stratified, randomised phase 2 trialUday R Popat, Rohtesh S Mehta, Roland Bassett, et al.
The Lancet. Haematology|September 21, 2019
Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trialAsra Ahmed, Samuel A Merrill, Fares Alsawah, et al.
The Lancet. Haematology|February 5, 2017
Recombinant factor IX Fc fusion protein in children with haemophilia B (Kids B-LONG): results from a multicentre, non-randomised phase 3 studyKathelijn Fischer, Roshni Kulkarni, Beatrice Nolan, et al.
The Lancet. Haematology|December 15, 2016
Mortality outcomes after busulfan-containing conditioning treatment and haemopoietic cell transplantation in patients with Gilbert's syndrome: a retrospective cohort studyGeorge B McDonald, Ashley T Evans, Jeannine S McCune, et al.
The Lancet. Haematology|February 7, 2017
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trialEsther N Oliva, Caterina Alati, Valeria Santini, et al.
The Lancet. Haematology|April 16, 2017
Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countriesAudrey Bonaventure, Rhea Harewood, Charles A Stiller, et al.
Pageof 73